Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKesson
Johnson and Johnson
Citi
Boehringer Ingelheim
Medtronic
Mallinckrodt
Cantor Fitzgerald
Chubb

Generated: April 22, 2018

DrugPatentWatch Database Preview

LYSODREN Drug Profile

« Back to Dashboard

When do Lysodren patents expire, and when can generic versions of Lysodren launch?

Lysodren is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in LYSODREN is mitotane. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the mitotane profile page.
Drug patent expirations by year for LYSODREN
Pharmacology for LYSODREN
Mechanism of ActionCytochrome P450 3A4 Inducers
Medical Subject Heading (MeSH) Categories for LYSODREN
Synonyms for LYSODREN
(+-)-1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane
(2,4'-Dichlorodiphenyl)dichloroethane
(o,p')-DDD
(o,p)-DDD
000M850
1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane
1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane for diagnostic uses (cancer investigation), >=98% (HPLC)
1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane, analytical standard
1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane, for diagnostic uses (cancer investigation), >=98% (HPLC)
1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane
1-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-2-chlorobenzene
1-Chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)benzene
1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene
1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene #
1-chloro-4-[2,2-dichloro-1-(2-chlorophenyl)ethyl]benzene
1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane
1,1-Dichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane
1,1-Dichloro-2,2-bis(2,4'-dichlorophenyl)ethane
1,2-bis(2,4'-dichlorophenyl)ethane
2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane
2-(o-Chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloroethane
2,2-Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane
2,4 -Dichlorodiphenyldichloroethane
2,4'-Ddd
2,4'-DDD 10 microg/mL in Cyclohexane
2,4'-DDD 100 microg/mL in Cyclohexane
2,4'-DDD, analytical standard
2,4'-DDD, PESTANAL(R), analytical standard
2,4'-Dichlorodiphenyldichloroethane
2,4'-Dichlorophenyldichlorethane
53-19-0
AB00052337_10
AB00052337-09
AB0010565
AC1L1HNV
AC1Q3H13
AI3-07575
AKOS006028802
AN-41639
AS-11690
Benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-
Benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-, (+-)-
Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-
Bristol Myers Squibb Brand of Mitotane
Bristol-Myers Squibb Brand of Mitotane
BRN 2056007
BSPBio_002517
C 3010
C14H10Cl4
CAS-53-19-0
CB 313
CB-313
CB313
CCG-40014
CCRIS 4397
CHEBI:6954
CHEBI:91626
CHEMBL1670
Chloditan
Chlodithan
Chlodithane
CS-1500
CTK8E2992
D00420
D0Z5OE
DB00648
DDD-o,p'
DDD, o,p'-
DivK1c_000703
DSSTox_CID_372
DSSTox_GSID_20372
DSSTox_RID_75548
DTXSID9020372
EINECS 200-166-6
EN300-37268
Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-
Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)- (8CI)
Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-(8CI)
Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-
Ethane,1-dichloro-
Ethane,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-
EU-0100251
FT-0605518
GTPL6957
HMS1923K19
HMS2091E07
HMS2232C16
HMS3260D04
HMS3369H10
HMS3655G06
HMS502D05
HSDB 3240
HY-13690
IDI1_000703
JWBOIMRXGHLCPP-UHFFFAOYSA-N
KB-146519
KBio1_000703
KBio2_002505
KBio2_005073
KBio2_007641
KBio3_002017
KBioGR_001237
KBioSS_002513
Khloditan
Khlodithan
Lopac0_000251
LP00251
LS-185
Lysodren (TN)
MCULE-2068358149
MFCD00000850
Mitotan
mitotane
Mitotane (JAN/USP/INN)
Mitotane (Lysodren)
Mitotane [USAN:INN:JAN]
Mitotane [USAN:USP:INN:BAN:JAN]
Mitotane, >=98% (HPLC)
Mitotane, United States Pharmacopeia (USP) Reference Standard
Mitotano
Mitotano [INN-Spanish]
Mitotanum
Mitotanum [INN-Latin]
MLS001335899
MLS001335900
MLS002152914
MLS002153233
MolPort-001-779-578
Mytotan
NCGC00015226-02
NCGC00015226-03
NCGC00015226-04
NCGC00015226-05
NCGC00015226-06
NCGC00015226-07
NCGC00015226-08
NCGC00015226-09
NCGC00015226-10
NCGC00015226-11
NCGC00015226-12
NCGC00091374-01
NCGC00091374-02
NCGC00091374-03
NCGC00091374-04
NCGC00091374-05
NCGC00091374-06
NCGC00256452-01
NCGC00260936-01
NCI-C04933
NCI60_003688
NINDS_000703
NSC 38721
NSC-38721
NSC-755849
NSC38721
NSC755849
o,p-DDD
o,p-Tde
o,p'-DDD
o,p'-DDD|||1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane|||Mitotane
o,p'-Dichlorodiphenyldichloroethane
o,p'-TDE
Opeprim
OR014096
OR145297
OR145298
ortho,para DDD
ortho,para-DDD
Pharmakon1600-00330082
Piprine-DDD, O-
Prestwick_75
PS694_SUPELCO
PubChem14974
s1732
SBI-0050239.P004
SC-18530
SCHEMBL4040
SMR000326696
SPBio_000792
Spectrum_001959
Spectrum2_000916
Spectrum3_000869
SPECTRUM330082
Spectrum4_000709
Spectrum5_002060
SR-01000075751
SR-01000075751-1
ST51016017
Tox21_110103
Tox21_110103_1
Tox21_302804
Tox21_500251
TR-018813
W-5031
WLN: GYGYR BG&R DG
Z425389592

US Patents and Regulatory Information for LYSODREN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb LYSODREN mitotane TABLET;ORAL 016885-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Cipla
US Army
Fuji
Citi
Chinese Patent Office
Moodys
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.